MedTrace Logo

Venous Irregularities, Flow and Perfusion in MS Study

NCT01593904 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2012-05-08

No results posted yet for this study

Summary

1. What is the true incidence of CCSVI in patients with MS in a study comparing MRI on MS patients and controls.
2. Are the beneficial outcomes from treatment placebo? By measuring changes in brain perfusion and Cerebrospinal flow before and after the procedure on a large number of patients to determine these outcomes

Conditions

  • Venous Irregularities, Flow and Perfusion in MS and Non-MS Participants

Sponsors & Collaborators

  • Synergy Health Concepts, Inc.

    lead INDUSTRY

Principal Investigators

  • John Joseph Hewett, MD · Study Principal Investigator

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01593904 on ClinicalTrials.gov